Skip to content

Clinical trials

Observational Alzheimer Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Observational Country / region: Canada Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20051
20071
20081
20091
20101
20112
20131
20144
20163
20181
20191
20201
20211
20225
20233
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting11
Unknown status5
Enrolling by invitation1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sunnybrook Health Sciences Centre3
University of Southern California3
Alzheimer's Disease Cooperative Study (ADCS)2
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal2
McGill University2
University Health Network, Toronto2
Bio Conscious Technologies Inc.1
Bruyère Health Research Institute.1
Centre for Addiction and Mental Health1
Dr. Sandra E Black1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease38
Cognitive Dysfunction22
Dementia14
Parkinson Disease5
Plaque, Amyloid5
Cognition Disorders4
Frontotemporal Dementia4
Lewy Body Disease4
Memory Disorders3
Pick Disease of the Brain3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.